|1.||Wilce, Jacqueline A: 2 articles (01/2012 - 12/2010)|
|2.||Wilce, Matthew C J: 2 articles (01/2012 - 12/2010)|
|3.||Del Borgo, Mark P: 1 article (01/2012)|
|4.||Krag, David N: 1 article (01/2012)|
|5.||Ambaye, Nigus D: 1 article (01/2012)|
|6.||Gunzburg, Menachem J: 1 article (01/2012)|
|7.||Pero, Stephanie C: 1 article (01/2012)|
|8.||Perlmutter, Patrick: 1 article (12/2010)|
|9.||Yap, Min Y: 1 article (12/2010)|
|10.||Clayton, Daniel J: 1 article (12/2010)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "G7-18NATE effectively inhibits the interaction of Grb7 with ErbB3 and focal adhesion kinase in cell lysates and, with the addition of a cell permeability sequence, inhibits the growth and migration of a number of breast cancer cell lines. "
05/21/2007 - "In this study, we have shown that both Penetratin- and Tat-conjugated G7-18NATE peptides are able to inhibit the proliferation of SK-BR-3, ZR-75-30, MDA-MB-361 and MDA-MB-231 breast cancer cells. "
12/01/2010 - "Its overexpression in several cancer types has implicated it in cancer progression and led to the development of the G7-18NATE cyclic peptide inhibitor. "
12/01/2010 - "The structure of the G7-18NATE peptide in complex with its target will facilitate the rational development of Grb7-targeted cancer therapeutics."
01/01/2012 - "The G7-18NATE cyclic peptide is reported to specifically inhibit the growth factor receptor bound protein 7 (Grb7) adapter protein, implicated in the progression of several cancer types, via interactions with its SH2 domain. "
|3.||Pancreatic Neoplasms (Pancreatic Cancer)
|3.||Focal Adhesion Protein-Tyrosine Kinases
|4.||GRB7 Adaptor Protein